Outstanding Growth of Clinical Immunoanalyzer Market is estimated to reach $4.95 Billion by 2025 | Roche, Abbott, Siemens, Beckman Coulter, Ortho-Clinical Diagnostics, Bio-Rad, BioMerieux
The report covers a forecast and an analysis of the Clinical Immunoanalyzer Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Clinical Immunoanalyzer Market along with the impact they have on the demand over the forecast period.
The Global Clinical Immunoanalyzer Market has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Clinical Immunoanalyzer market size to maintain the average annual growth rate of 0.05275340306 from US$ 2900.0 Million in 2015 to US$ 3750.0 Million in 2019, market analysts believe that in the next few years, Clinical Immunoanalyzer market size will be further expanded, we expect that by 2025, The market size of the Clinical Immunoanalyzer will reach US$ 4950.0 Million.
Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/286784 .
According to the market research study, Immunoassay is test to measure the concentration or presence of a molecule via an antibody or an antigen. The molecule detected through this test is termed as an ‘analyte’ and in some cases also as protein. Clinical Immunoanalyzer is a medical diagnostic device that identifies and quantifies specific analytes in the blood or samples of body fluids by using immunoassay processes, such as, immunoprecipitation, particle immunoassays, immunonephelometry, radioimmunoassay, enzyme immunoassay, fluorescent immunoassay, and chemiluminescent immunoassays. Clinical Immunoanalyzer is used in the medical sector for the detection of bacteria & viral toxins, drug monitoring, allergy testing, and cancer markers.
Some of the significant key factors driving the growth of the Global Clinical Immunoanalyzer Market are rapid growth in the prevalence of chronic & infectious diseases around the globe, increasing demand for diagnostics, and increasing investments in Research & Development to develop new tests for the diagnosis of the diseases.
On the basis of Regional analysis, North America and Europe holds major share in global Clinical Immunoanalyzer market. Moreover, Asia-Pacific is expected to record higher growth rate in Clinical Immunoanalyzer Market during the forecast year.
Global Key Players:
1 Roche Diagnostics
4 Beckman Coulter
5 Ortho-Clinical Diagnostics
9 Werfen Life
10 Thermo Fisher Scientific
11 Tosoh Corporation
12 Randox Laboratories
14 Transasia and More………………
Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Clinical Immunoanalyzer Market Report 2021” @ https://www.businessindustryreports.com/buy-now/286784/single .
Product Type Segmentation
Latest Medical Industry News:
Roche (March 30, 2021) - Roche’s Evrysdi approved by European Commission as first and only at home treatment for spinal muscular atrophy - Roche today announced that the European Commission (EC) has approved Evrysdi (risdiplam) for the treatment of 5q spinal muscular atrophy (SMA) in patients two months of age and older, with a clinical diagnosis of SMA Type 1, Type 2 or Type 3 or with one to four SMN2 copies. SMA is a leading genetic cause of death in infants and 5q SMA is the most common form of the disease. The condition causes muscle weakness and progressive loss of movement and significant unmet need remains, particularly in adults living with this condition.
“Today’s approval of Evrysdi, the first and only SMA treatment with proven efficacy that can be taken at home, potentially transforms treatment options for a broad range of people with SMA living in the EU,” said Levi Garraway, M.D., Ph. D., Roche’s Chief Medical Officer and Head of Global Product Development. “By avoiding the need for in-hospital administration, Evrysdi can reduce the treatment burden on those living with SMA, their caregivers and healthcare systems. We thank the SMA community for their partnership, the trust they have placed in us and their unyielding commitment to achieve this significant milestone.”
The approval is based on data from two clinical studies, designed to represent a broad spectrum of people living with SMA: FIREFISH in symptomatic Type 1 infants aged 2 to 7 months and SUNFISH in symptomatic Type 2 and 3 children and adults aged 2 to 25 years. SUNFISH is the first and only placebo-controlled trial to include adults with Types 2 and 3 SMA. Evrysdi demonstrated a favourable efficacy and safety profile, with the safety profile established across both trials.
"We welcome today’s approval of Evrysdi for people with SMA in Europe, and are proud of the role we have played in its development and of our partnership with Roche,” said Dr Nicole Gusset, President of SMA Europe. “A recent survey conducted by SMA Europe showed that a large proportion of people with SMA in the EU were not receiving an approved treatment which leaves them feeling helpless and frustrated. It is vital that we work together with health authorities, regulators and industry to ensure we can get this medicine to the patients who need it as soon as possible.’’
Roche is working closely with reimbursement and assessment bodies in European countries to enable broad and rapid access to patients in need. Evrysdi will be accessible to patients in Germany in the coming days and in France from early April through the cohort Temporary Authorization for Use. Reimbursement dossiers have been submitted in many countries in anticipation of today’s decision by the European Commission to minimise any delay in patient access.
The decision from the European Commission follows a positive recommendation from the Committee for Medicinal Products for Human Use (CHMP) in February 2021. The review was completed under the accelerated assessment pathway for medicines, which is offered to medicines deemed to be of major interest for public health and therapeutic innovation. This approval is applicable to all 27 European Union member states, as well as Iceland, Norway, and Liechtenstein. Evrysdi was granted PRIME designation by the European Medicines Agency (EMA) in 2018 and Orphan Drug Designation in 2019. Maintenance of Orphan Drug Designation was recently confirmed by the Committee for Orphan Medicinal Products based on the assumption of Evrysdi’s significant benefit over existing treatments. Evrysdi has been approved in 38 countries and submitted in further 33 countries.
Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/286784 .
Major Points in Table of Contents:
Global Clinical Immunoanalyzer Market Report 2021
1 Clinical Immunoanalyzer Product Definition
2 Global Clinical Immunoanalyzer Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Clinical Immunoanalyzer Shipments
2.2 Global Manufacturer Clinical Immunoanalyzer Business Revenue
2.3 Global Clinical Immunoanalyzer Market Overview
2.4 COVID-19 Impact on Clinical Immunoanalyzer Industry
3 Manufacturer Clinical Immunoanalyzer Business Introduction
3.1 Roche Diagnostics Clinical Immunoanalyzer Business Introduction
3.2 Abbott Clinical Immunoanalyzer Business Introduction
3.3 Siemens Clinical Immunoanalyzer Business Introduction
3.4 Beckman Coulter Clinical Immunoanalyzer Business Introduction
3.5 Ortho-Clinical Diagnostics Clinical Immunoanalyzer Business Introduction
3.6 Bio-Rad Clinical Immunoanalyzer Business Introduction
BusinessindustryReports.com is a digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that hold the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic, and therefore successful decisions for themselves.
Business Industry Reports
Pune – India
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Outstanding Growth of Clinical Immunoanalyzer Market is estimated to reach $4.95 Billion by 2025 | Roche, Abbott, Siemens, Beckman Coulter, Ortho-Clinical Diagnostics, Bio-Rad, BioMerieux here
News-ID: 2264222 • Views: 551
More Releases from Business Industry Reports
Tetracaine Market Exhibits a Lucrative Growth Potential during 2021-2025 | Endo …
BusinessIndustryReports has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Tetracaine Market” Research Report 2021 provides an in-depth analysis of the Tetracaine with the forecast of market size and growth. The analysis includes addressable market, market by volume, market share by business type and by segment (external and in-house). The research study examines the Tetracaine on the basis of a number of criteria,
Cyber Warfare Market Evenly Poised To Reach A Market Value of US$ By Share, Size …
Overview of Global Cyber Warfare Market: This report provides in-depth study of “Global Cyber Warfare Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cyber Warfare Market report also provides an in-depth survey of key players in the market organization. According to the market research study, the Cyber Warfare is virtual conflict between state, organization, or country by the use of computer technology to disrupt activities
Covid-19 Impact on Cranio Maxillofacial Implant Market 2021-2025: Business Growt …
Overview of Global Cranio Maxillofacial Implant Market: This report provides in-depth study of “Global Cranio Maxillofacial Implant Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cranio Maxillofacial Implant Market report also provides an in-depth survey of key players in the market organization. According to the market research study, Craniomaxillofacial Implants are medical implants used in surgeries of maxillofacial region such as, head, face, neck, oral,
Beginning of the bloom: The Rise of the Biohacking Market 2021-2025 | Global Key …
Global Biohacking Market Synopsis: The report covers a forecast and an analysis of the Biohacking Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Biohacking Market along with the impact they have on the demand over the forecast
More Releases for Clinical
Are you spending more time with yellow files than with patients? Healthbridge can change that with our intuitive and easy to use clinical platform that is designed specifically for the medical practitioner at the practice. smaller2 Easily access patient information Cloud-based technology enables you to store rich clinical information that can be easily accessed as and when you need it. Medical billing software innovation Become a paperless practice Create scripts, sick notes, and clinical notes electronically. Plus, have
Clinical Research and Clinical Trials Summit
Clinical Research 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation. This is the premier interdisciplinary forum for
Clinical Trial Management System
According to a new market report published by Persistence Market Research “Global Market Study on Clinical Trial Management System: Asia to Witness Highest Growth by 2019” the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019. Request Report TOC @ https://www.persistencemarketresearch.com/methodology/3017
Clinical Nutrition Conference 2018
Clinical nutrition is essential for patients in healthcare to deal with sickness, injuries, surgery and for proper recovery. It helps in preventing malnutrition, restoring body tissue and boosting energy and immunity in the body. It can be provided with a proper diet plan and feeding the patient with essential foods that revive the patient’s body the patient can also be given healthy supplements for proteins, vitamins etc. The preferred route
According to a recent market report published by Persistence Market Research titled “Clinical Communication and Collaboration Market: Global Industry Analysis (2012–2016) and Forecast (2017–2025),” revenue from the global clinical communication and collaboration market was US$ 138.5 Mn in 2012 and US$ 214.8 Mn in 2016, representing a CAGR of 11.6% from 2012 to 2016. This revenue growth is attributed to addition of new features in clinical communication and collaboration solutions.
Europe Clinical Nutrition Market
According to the report “Europe Clinical Nutrition Market,” published by Market Data Forecast, the global market is projected to reach USD 12.45 billion by 2021 from USD 9.65 billion in 2016, at a CAGR of 5.29% from 2016 to 2021. Clinical nutrition is the practice of analysing if a person is consuming an adequate amount of nutrients for good health. A clinical nutritionist is concerned with how nutrients in food are